Attenuated rubella viruses. Laboratory and clinical characteristics.
D000328:Adult; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D001168:Arthritis / Q000209:etiology; D001769:Blood / Q000382:microbiology; D002648:Child; D046508:Culture Techniques; D004285:Dogs; D004372:Ducks; D004622:Embryo, Mammalian; D004625:Embryo, Nonmammalian; D005260:Female; D000882:Haplorhini; D006801:Humans; D007115:Immunization Schedule; D007668:Kidney; D010614:Pharynx / Q000382:microbiology; D011817:Rabbits; D012409:Rubella / Q000276:immunology* / Q000517:prevention & control; D012411:Rubella Vaccine / Q000009:adverse effects; D012412:Rubella virus / Q000302:isolation & purification / Q000472:pathogenicity; D013997:Time Factors; D014611:Vaccination; D014765:Viral Vaccines; D014776:Virus Cultivation
D000906:Antibodies; D012411:Rubella Vaccine; D014765:Viral Vaccines